Hempacco Co, INC
Market Movers (8-K)
OTC.Pink
HPCO
Hempacco Co, INCHempacco Co. held its annual meeting, resulting in the election of five directors and the approval of other proposals, while also noting the resignation of two board members.
OTC.Pink
HPCO
Hempacco Co, INCHempacco Co. has received notice from Nasdaq that its securities will be delisted due to non-compliance with listing rules regarding annual shareholder meetings and filing of periodic financial reports.
Worse than expected
OTC.Pink
HPCO
Hempacco Co, INCHempacco Co. received a notice from Nasdaq regarding its delinquent quarterly report, potentially leading to delisting of its stock.
Worse than expected
Delay expected
OTC.Pink
HPCO
Hempacco Co, INC8-K: Hempacco Co. Faces Nasdaq Delisting Threat Due to Stockholder Deficit, Issues Shares to Settle Debt
Hempacco Co. received a delisting notice from Nasdaq due to a stockholder deficit and issued shares to settle a debt.
Worse than expected
OTC.Pink
HPCO
Hempacco Co, INCHempacco Co. has appointed Paul Glavine and Harrison Newlands as independent directors to its board, filling two vacant positions.
OTC.Pink
HPCO
Hempacco Co, INCHempacco Co. has received a notice from Nasdaq for not meeting the minimum $1.00 bid price requirement, placing its listing at risk.
Worse than expected
Annual Reports (10-K)
OTC.Pink
HPCO
Hempacco Co, INCHempacco Co. Inc.'s 2023 annual report reveals a year of strategic acquisitions, joint ventures, and financial complexities, including a net loss of $13.4 million.
Delay expected
Capital raise
Worse than expected
New Public Companies (S-1)
OTC.Pink
HPCO
Hempacco Co, INCHempacco Co., Inc. has filed an S-1 registration statement for the resale of up to 6,600,295 shares of common stock by selling stockholders following recent private placement transactions.
Capital raise
Worse than expected